Depocyt and disease progression Patient Reports February 09, 2010
Depocyt Side Effects Report #5725289-8
Depocyt side effect was reported by a Physician from NORWAY on Apr 11, 2008. Female patient, 53 years of age, was diagnosed with t-cell lymphoma and was treated with Depocyt. After drug was administered, patient experienced the following side effects: arachnoiditis, decerebration, disease progression, hyperaesthesia, neurotoxicity, posturing, pyrexia, somnolence. Depocyt dosage: 50 MG; 1X; INTH. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, METHOTREXATE, DESMOPRESSIN. Patient was hospitalized. Patient recovered.
Depocyt Side Effects Report #5023790-6
Depocyt side effect was reported by a Physician from UNITED STATES on May 22, 2006. Female patient, 49 years of age, was diagnosed with metastases to meninges and was treated with Depocyt. After drug was administered, patient experienced the following side effects: arachnoiditis, back pain
, condition aggravated, depressed level of consciousness, disease progression, dysphagia, headache
, hypokalaemia, mental status changes. Depocyt dosage: 50 MG; X1; INTH. During the same period patient was treated with TEMODAR, TEMOZOLOMIDE, DEXAMETHASONE, KEPPRA, ZOFRAN, MORPHINE. Patient was hospitalized. Patient died on 05/07/2006.Depocyt Side Effects Report #5536064-1
Depocyt side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2007. Male patient, 47 years of age, was diagnosed with metastases to meninges and was treated with Depocyt. After drug was administered, patient experienced the following side effects: bedridden, cerebral haemorrhage, cns ventriculitis, csf lymphocyte count increased, csf white blood cell count positive, depressed level of consciousness, disease progression, ependymitis. Depocyt dosage: 50 MG; XL; INTH. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE, RITUXAN. Patient died.
Depocyt Side Effects Report #5775437-9
Depocyt side effect was reported by a Pharmacist from UNITED STATES on May 28, 2008. Female patient was diagnosed with metastases to meninges and was treated with Depocyt. After drug was administered, patient experienced the following side effects: disease progression, nausea
. Depocyt dosage: 50 MG;QOW;ITVN. Patient recovered.Depocyt Side Effects Report #5788253-9
Depocyt side effect was reported by a Pharmacist from UNITED STATES on June 11, 2008. Female patient was diagnosed with metastases to meninges and was treated with Depocyt. After drug was administered, patient experienced the following side effects: disease progression, nausea
. Depocyt dosage: 50 MG;QOW;ITVN. Patient recovered.Depocyt Side Effects Report #5979410-7
Depocyt side effect was reported by a Physician from UNITED KINGDOM on Nov 12, 2008. Female patient, 53 years of age, was diagnosed with lymphoma
and was treated with Depocyt. After drug was administered, patient experienced the following side effects: cauda equina syndrome, disease progression. Depocyt dosage: 50 MG; QM; INTH. Patient was hospitalized and became disabled. Patient recovered.Depocyt Side Effects Report #5804290-X
Depocyt side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 26, 2008. Female patient, 33 years of age, was diagnosed with lymphoma
and was treated with Depocyt. After drug was administered, patient experienced the following side effects: ataxia
, balance disorder, central nervous system inflammation, disease progression, headache
, intracranial pressure increased, neurotoxicity, papilloedema, visual impairment. Depocyt dosage: 50 MG; INTH. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE. Patient recovered.Depocyt Side Effects Report #6107477-4
Depocyt side effect was reported by a Physician from DENMARK on Jan 05, 2009. Female patient, 20 years of age, was diagnosed with leukaemia and was treated with Depocyt. After drug was administered, patient experienced the following side effects: disease progression, headache
, intracranial pressure increased, papilloedema, vision blurred. Depocyt dosage: 50 MG; 1X;INTH. Patient was hospitalized. Patient recovered.Depocyt Side Effects Report #5671581-5
Depocyt side effect was reported by a Physician from FRANCE on Feb 28, 2008. Female patient, 64 years of age, was diagnosed with central nervous system lymphoma and was treated with Depocyt. After drug was administered, patient experienced the following side effects: cauda equina syndrome, disease progression, faecal incontinence, inflammation, mobility decreased, neurotoxicity, procedural complication, urinary incontinence
. Depocyt dosage: 50 MG;X4;. During the same period patient was treated with MABTHERA, CHLORAMINOPHEN, CORTANCYL, TAHOR, AMILORIDE HYDROCHLORIDE, ALPRESS, MODOPAR. Patient was hospitalized. Patient recovered.Depocyt Side Effects Report #5844616-4
Depocyt side effect was reported by a Physician from FINLAND on July 28, 2008. Female patient, 64 years of age, was diagnosed with central nervous system lymphoma and was treated with Depocyt. After drug was administered, patient experienced the following side effects: coma, depressed level of consciousness, disease progression, dyspnoea, neurotoxicity, pyrexia. Depocyt dosage: 50 MG; 1X; INTH. During the same period patient was treated with IFOSFAMIDE, HOLOXAN, DEXAMETHASONE, METHOTREXATE. Patient recovered.
Depocyt Side Effects Report #5776160-7
Depocyt side effect was reported by a Physician from BELGIUM on May 30, 2008. Female patient, 77 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Depocyt. After drug was administered, patient experienced the following side effects: acute leukaemia, disease progression, encephalopathy, pain
, pyrexia. Depocyt dosage: unknown. During the same period patient was treated with METHOTREXATE, CYTARABINE, DEXAMETHASONE, GLAZIDIM. Patient was hospitalized. Patient recovered.Depocyt Side Effects Report #5804289-3
Depocyt side effect was reported by a Physician from BELGIUM on June 27, 2008. Female patient, 77 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Depocyt. After drug was administered, patient experienced the following side effects: arachnoiditis, central nervous system leukaemia, colitis, disease progression, encephalopathy, neurotoxicity, overdose, pain
. Depocyt dosage: 50 MG, QOW; INTH. During the same period patient was treated with METHOTREXATE, DEXAMETHASONE, GLAZIDIM, LORAZEPAM, CITALOPRAM HYDROBROMIDE, ZANTAC, METFORMIN, CETIRIZINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Depocyt Side Effects Report #5318445-4
Depocyt side effect was reported by a Consumer or non-health professional from AUSTRIA on Apr 16, 2007. Male patient, child 5 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Depocyt. After drug was administered, patient experienced the following side effects: confusional state, disease progression, hallucination, mucosal inflammation, somnolence. Depocyt dosage: 35 MG. Patient died.
Depocyt and disease progression 